Evidence map›Paper›PMID 40324997›Full record

ArticleBDJ open2025

Comparison of the remineralization effectiveness of three remineralizing agents on artificial enamel lesions: an in vitro study.

Maha Mohamed Montaser, Heba Youssef, Ghada Mohamed Mahmoud

Abstract read
In one paragraph

Article in BDJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Enamel Remineralizing Agents: State of the Art.Materials (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maha Mohamed MontaserThe Arab Academy for Science, Technology and Maritime Transport- College of Dentistry-Alamein Campus, Alexandria, Egypt. maha_mon@aast.edu.ORCID http://orcid.org/0000-0002-7166-9102
Heba YoussefThe Arab Academy for Science, Technology and Maritime Transport- College of Dentistry-Alamein Campus, Alexandria, Egypt.
Ghada Mohamed MahmoudThe pediatric Dentistry department at the Arab Academy for Science, Technology and Maritime Transport- College of Dentistry-Alamein Campus, Alexandria, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEarly enamel demineralization can be reversed through remineralization, which restores lost minerals to strengthen enamel and prevent decay.

aimThis study evaluated the remineralization efficiency of three commercial treatments on artificially demineralized primary enamel.

methodsForty exfoliated primary anterior teeth were demineralized and divided into five groups: untreated control, artificial saliva, fluoridated toothpaste, Curasept toothpaste, and BioMin toothpaste. The treatments were applied for 28 days. Remineralization efficacy was assessed using Vickers microhardness testing, surface roughness measurement, and Scanning electron microscope combined with EDX (SEM-EDX). One-way ANOVA and Tukey's HSD test were used for statistical analysis.

resultsMicrohardness and surface roughness tests confirmed BioMin's superior remineralization potential. Scanning electron microscopy showed that untreated enamel exhibited extensive demineralization, whereas treated groups displayed varying degrees of remineralization. BioMin demonstrated the highest calcium, phosphate, and fluoride incorporation, followed by Curasept and fluoridated toothpaste. The artificial saliva group showed no significant improvement over the control.

conclusionBioMin, followed by Curasept and fluoridated toothpaste, effectively remineralized demineralized enamel. BioMin's bioactive glass formulation provided the highest mineral gain, suggesting its potential for non-invasive enamel restoration in pediatric dentistry.

Identifiers

PMID40324997
PMCPMC12053640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.